Florida Cancer Specialists & Research Institute Utilizes Proprietary Real-World Data in First Study of Treatment Response in Lower-Risk Myelodysplastic Syndrome Patients Treated with Erythropoiesis-Stimulating Agents – NEWSnet – News… as it used to be
